Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-003194-27Phase 4Completed
Phase 4, randomised, double-blind trial in functional dyspepsia (FD) comparing Mirtazapine with Placebo (2 arms). Primary endpoint: Global dyspepsia symptom score improvement at 8 weeks. Started Aug 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-003194-27.